NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . November 17th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Rockefeller University Press - How HIV vaccine might have increased odds of infection

HIV/AIDS - Research reports on HIV/AIDS from University of North Carolina provide new insights

HIV/AIDS - Studies from A. Clark and co-researchers update current data on HIV/AIDS

HIV/AIDS Co-Infection - Research from M.J. Mimiaga and co-researchers in the area of HIV/AIDS co-infection published

 HIV/AIDS Co-Infection - Research reports on HIV/AIDS co-infection from A. Weinberg and colleagues provide new insights

SIVR - Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial

Smallpox Vaccines - Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)

Bavarian Nordic A/S - Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE

Cancer Vaccines - Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2008

Progenics Pharmaceuticals, Inc. - Progenics Selects Small-Molecule Hepatitis C Drug Candidate for Clinical Development


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login